Nitrate, nitrite and nitric oxide reductases: From the last universal common ancestor to modern bacterial pathogens

Current Opinion in Microbiology

Volumn 29, Issue , 2016, Pages 1-8

  Vázquez Torres, Andrés ^a,b   Bäumler, Andreas J ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Veterans Affairs Eastern Colorado Health Care System   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE REDUCTASE; NITROGEN OXIDE; NITROUS OXIDE; OXIDOREDUCTASE; QUINOL OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; CYTOCHROME; NITRIC-OXIDE REDUCTASE; NITRITE;

AEROBIC METABOLISM; ANTIBACTERIAL ACTIVITY; BACTERIAL CELL; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BIOENERGY; BIOSYNTHESIS; CELL GROWTH; CYTOTOXICITY; DETOXIFICATION; ELECTROCHEMICAL ANALYSIS; ENTEROBACTERIACEAE; ENZYME ACTIVITY; HOMEOSTASIS; HUMAN; LAST COMMON ANCESTOR; MYCOBACTERIUM TUBERCULOSIS; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PROTON TRANSPORT; RESPIRATORY CHAIN; REVIEW; ANAEROBIC GROWTH; ANTIBIOTIC RESISTANCE; BACTERIUM; ELECTRON TRANSPORT; ENERGY METABOLISM; METABOLISM; PATHOGENICITY;

ANAEROBIOSIS; BACTERIA; CYTOCHROMES; DRUG RESISTANCE, BACTERIAL; ELECTRON TRANSPORT; ENERGY METABOLISM; HOMEOSTASIS; NITRATE REDUCTASES; NITRIC OXIDE; NITRITES; OXIDOREDUCTASES;

EID: 84942673553     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2015.09.002     Document Type: Review

References (72)

1. Tsolis R.M., Adams L.G., Ficht T.A., Baumler A.J. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect Immun 1999, 67:4879-4885.
2. Khan S.A., Everest P., Servos S., Foxwell N., Zahringer U., Brade H., Rietschel E.T., Dougan G., Charles I.G., Maskell D.J. A lethal role for lipid A in Salmonella infections. Mol Microbiol 1998, 29:571-579.
3. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988, 333:664-666.
4. Zhu L., Gunn C., Beckman J.S. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992, 298:452-457.
5. De Groote M.A., Granger D., Xu Y., Campbell G., Prince R., Fang F.C. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc Natl Acad Sci U S A 1995, 92:6399-6403.
6. Henard C.A., Vazquez-Torres A. Nitric oxide and Salmonella pathogenesis. Front Microbiol 2011, 2:84.
7. Umezawa K., Akaike T., Fujii S., Suga M., Setoguchi K., Ozawa A., Maeda H. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect Immun 1997, 65:2932-2940.
8. Mastroeni P., Vazquez-Torres A., Fang F.C., Xu Y., Khan S., Hormaeche C.E., Dougan G. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 2000, 192:237-248.
9. Lopez C.A., Winter S.E., Rivera-Chavez F., Xavier M.N., Poon V., Nuccio S.P., Tsolis R.M., Baumler A.J. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. MBio 2012, 3.
10. Szabo C., Ischiropoulos H., Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007, 6:662-680.
11. Dudhgaonkar S.P., Tandan S.K., Kumar D., Raviprakash V., Kataria M. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats. Inflammopharmacology 2007, 15:188-195.
12. Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., Laughlin R.C., Gomez G., Wu J., Lawhon S.D., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
13. Lawley T.D., Bouley D.M., Hoy Y.E., Gerke C., Relman D.A., Monack D.M. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 2008, 76:403-416.
14. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Dore J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
15. Gophna U., Sommerfeld K., Gophna S., Doolittle W.F., Veldhuyzen van Zanten S.J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006, 44:4136-4141.
16. Baumgart M., Dogan B., Rishniw M., Weitzman G., Bosworth B., Yantiss R., Orsi R.H., Wiedmann M., McDonough P., Kim S.G., et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 2007, 1:403-418.
17. Walker A.W., Sanderson J.D., Churcher C., Parkes G.C., Hudspith B.N., Rayment N., Brostoff J., Parkhill J., Dougan G., Petrovska L. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011, 11:7.
18. Haberman Y., Tickle T.L., Dexheimer P.J., Kim M.O., Tang D., Karns R., Baldassano R.N., Noe J.D., Rosh J., Markowitz J., et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 2014, 124:3617-3633.
19. Gevers D., Kugathasan S., Denson L.A., Vazquez-Baeza Y., Van Treuren W., Ren B., Schwager E., Knights D., Song S.J., Yassour M., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392.
20. Lundberg J.O., Hellstrom P.M., Lundberg J.M., Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994, 344:1673-1674.
21. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111:871-885.
22. Winter S.E., Baumler A.J. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 2014, 5:71-73.
23. Iobbi C., Santini C.L., Bonnefoy V., Giordano G. Biochemical and immunological evidence for a second nitrate reductase in Escherichia coli K12. Eur J Biochem 1987, 168:451-459.
24. Wang W., Kinkel T., Martens-Habbena W., Stahl D.A., Fang F.C., Hansen E.J. The Moraxella catarrhalis nitric oxide reductase is essential for nitric oxide detoxification. J Bacteriol 2011, 193:2804-2813.
25. DeMoss J.A., Hsu P.Y. NarK enhances nitrate uptake and nitrite excretion in Escherichia coli. J Bacteriol 1991, 173:3303-3310.
26. Stewart V., Lu Y., Darwin A.J. Periplasmic nitrate reductase (NapABC enzyme) supports anaerobic respiration by Escherichia coli K-12. J Bacteriol 2002, 184:1314-1323.
27. Potter L.C., Cole J.A. Essential roles for the products of the napABCD genes, but not napFGH, in periplasmic nitrate reduction by Escherichia coli K-12. Biochem J 1999, 344 Pt(1):69-76.
28. Unden G., Bongaerts J. Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta 1997, 1320:217-234.
29. Garland P.B., Downie J.A., Haddock B.A. Proton translocation and the respiratory nitrate reductase of Escherichia coli. Biochem J 1975, 152:547-559.
30. Jones R.W., Lamont A., Garland P.B. The mechanism of proton translocation driven by the respiratory nitrate reductase complex of Escherichia coli. Biochem J 1980, 190:79-94.
31. Lopez C.A., Rivera-Chavez F., Byndloss M.X., Baumler A. The periplasmic nitrate reductase NapABC supports luminal growth of Salmonella enterica serovar Typhimurium during colitis. Infect Immun 2015.
32. Rivera-Chavez F., Winter S.E., Lopez C.A., Xavier M.N., Winter M.G., Nuccio S.P., Russell J.M., Laughlin R.C., Lawhon S.D., Sterzenbach T., et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog 2013, 9:e1003267.
33. Gilberthorpe N.J., Poole R.K. Nitric oxide homeostasis in Salmonella typhimurium: roles of respiratory nitrate reductase and flavohemoglobin. J Biol Chem 2008, 283:11146-11154.
34. Sohaskey C.D. Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol 2008, 190:2981-2986.
35. Tan M.P., Sequeira P., Lin W.W., Phong W.Y., Cliff P., Ng S.H., Lee B.H., Camacho L., Schnappinger D., Ehrt S., et al. Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses. PLoS One 2010, 5:e13356.
36. Eoh H., Rhee K.Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2013, 110:6554-6559.
37. Cunningham-Bussel A., Zhang T., Nathan C.F. Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression. Proc Natl Acad Sci U S A 2013, 110:E4256-E4265.
38. Akhtar S., Khan A., Sohaskey C.D., Jagannath C., Sarkar D. Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of Mycobacterium tuberculosis. J Bacteriol 2013, 195:4592-4599.
39. Jung J.Y., Madan-Lala R., Georgieva M., Rengarajan J., Sohaskey C.D., Bange F.C., Robinson C.M. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infect Immun 2013, 81:3198-3209.
40. Williams M.J., Shanley C.A., Zilavy A., Peixoto B., Manca C., Kaplan G., Orme I.M., Mizrahi V., Kana B.D. bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs. Infect Immun 2015, 83:544-550.
41. Watmough N.J., Field S.J., Hughes R.J., Richardson D.J. The bacterial respiratory nitric oxide reductase. Biochem Soc Trans 2009, 37:392-399.
42. Gaston B., Ratjen F., Vaughan J.W., Malhotra N.R., Canady R.G., Snyder A.H., Hunt J.F., Gaertig S., Goldberg J.B. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am J Respir Crit Care Med 2002, 165:387-390.
43. Vareille M., de Sablet T., Hindre T., Martin C., Gobert A.P. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 2007, 104:10199-10204.
44. Lewis A.M., Matzdorf S.S., Endres J.L., Windham I.H., Bayles K.W., Rice K.C. Examination of the Staphylococcus aureus nitric oxide reductase (saNOR) reveals its contribution to modulating intracellular NO levels and cellular respiration. Mol Microbiol 2015, 96:651-669.
45. Barraud N., Hassett D.J., Hwang S.H., Rice S.A., Kjelleberg S., Webb J.S. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol 2006, 188:7344-7353.
46. Kakishima K., Shiratsuchi A., Taoka A., Nakanishi Y., Fukumori Y. Participation of nitric oxide reductase in survival of Pseudomonas aeruginosa in LPS-activated macrophages. Biochem Biophys Res Commun 2007, 355:587-591.
47. Arai H., Iiyama K. Role of nitric oxide-detoxifying enzymes in the virulence of Pseudomonas aeruginosa against the silkworm, Bombyx mori. Biosci Biotechnol Biochem 2013, 77:198-200.
48. Stevanin T.M., Moir J.W., Read R.C. Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infect Immun 2005, 73:3322-3329.
49. Falsetta M.L., McEwan A.G., Jennings M.P., Apicella M.A. Anaerobic metabolism occurs in the substratum of gonococcal biofilms and may be sustained in part by nitric oxide. Infect Immun 2010, 78:2320-2328.
50. Shimizu T., Tsutsuki H., Matsumoto A., Nakaya H., Noda M. The nitric oxide reductase of enterohaemorrhagic Escherichia coli plays an important role for the survival within macrophages. Mol Microbiol 2012, 85:492-512.
51. Richardson D.J. Bacterial respiration: a flexible process for a changing environment. Microbiology 2000, 146(Pt 3):551-571.
52. Blomberg M.R., Siegbahn P.E. Why is the reduction of NO in cytochrome c dependent nitric oxide reductase (cNOR) not electrogenic?. Biochim Biophys Acta 2013, 1827:826-833.
53. Matsumoto Y., Tosha T., Pisliakov A.V., Hino T., Sugimoto H., Nagano S., Sugita Y., Shiro Y. Crystal structure of quinol-dependent nitric oxide reductase from Geobacillus stearothermophilus. Nat Struct Mol Biol 2012, 19:238-245.
54. Gardner A.M., Helmick R.A., Gardner P.R. Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli. J Biol Chem 2002, 277:8172-8177.
55. Su S., Panmanee W., Wilson J.J., Mahtani H.K., Li Q., Vanderwielen B.D., Makris T.M., Rogers M., McDaniel C., Lipscomb J.D., et al. Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS One 2014, 9:e91813.
56. Householder T.C., Fozo E.M., Cardinale J.A., Clark V.L. Gonococcal nitric oxide reductase is encoded by a single gene, norB, which is required for anaerobic growth and is induced by nitric oxide. Infect Immun 2000, 68:5241-5246.
57. Cardinale J.A., Clark V.L. Determinants of nitric oxide steady-state levels during anaerobic respiration by Neisseria gonorrhoeae. Mol Microbiol 2005, 58:177-188.
58. Sharma V., Wikstrom M. A structural and functional perspective on the evolution of the heme-copper oxidases. FEBS Lett 2014, 588:3787-3792.
59. Ducluzeau A.L., van Lis R., Duval S., Schoepp-Cothenet B., Russell M.J., Nitschke W. Was nitric oxide the first deep electron sink?. Trends Biochem Sci 2009, 34:9-15.
60. Ducluzeau A.L., Schoepp-Cothenet B., van Lis R., Baymann F., Russell M.J., Nitschke W. The evolution of respiratory O2/NO reductases: an out-of-the-phylogenetic-box perspective. J R Soc Interface 2014, 11. 20140196.
61. Saraste M., Castresana J. Cytochrome oxidase evolved by tinkering with denitrification enzymes. FEBS Lett 1994, 341:1-4.
62. Mason M.G., Shepherd M., Nicholls P., Dobbin P.S., Dodsworth K.S., Poole R.K., Cooper C.E. Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nat Chem Biol 2009, 5:94-96.
63. Husain M., Jones-Carson J., Liu L., Song M., Saah J.R., Troxell B., Mendoza M., Hassan H., Vazquez-Torres A. Ferric uptake regulator-dependent antinitrosative defenses in Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 2014, 82:333-340.
64. Gusarov I., Shatalin K., Starodubtseva M., Nudler E. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 2009, 325:1380-1384.
65. McCollister B.D., Hoffman M., Husain M., Vazquez-Torres A. Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake. Antimicrob Agents Chemother 2011, 55:2189-2196.
66. Zemke A.C., Gladwin M.T., Bomberger J.M. Sodium nitrite blocks the activity of aminoglycosides against Pseudomonas aeruginosa Biofilms. Antimicrob Agents Chemother 2015, 59:3329-3334.
67. Jones-Carson J., Zweifel A.E., Tapscott T., Austin C., Brown J.M., Jones K.L., Voskuil M.I., Vazquez-Torres A. Nitric oxide from IFNγ-primed macrophages modulates the antimicrobial activity of beta-lactams against the intracellular pathogens Burkholderia pseudomallei and Nontyphoidal Salmonella. PLoS Negl Trop Dis 2014, 8:e3079.
68. van Sorge N.M., Beasley F.C., Gusarov I., Gonzalez D.J., von Kockritz-Blickwede M., Anik S., Borkowski A.W., Dorrestein P.C., Nudler E., Nizet V. Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development. J Biol Chem 2013, 288:6417-6426.
69. Cunningham-Bussel A., Bange F.C., Nathan C.F. Nitrite impacts the survival of Mycobacterium tuberculosis in response to isoniazid and hydrogen peroxide. Microbiologyopen 2013, 2:901-911.
70. Ouadrhiri Y., Scorneaux B., Sibille Y., Tulkens P.M. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother 1999, 43:1242-1251.
71. Propst K.L., Troyer R.M., Kellihan L.M., Schweizer H.P., Dow S.W. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother 2010, 54:1785-1792.
72. Zemke A.C., Shiva S., Burns J.L., Moskowitz S.M., Pilewski J.M., Gladwin M.T., Bomberger J.M. Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells. Free Radic Biol Med 2014, 77:307-316.